期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Ruptured hepatocellular carcinoma following chemoembolization:a western experience 被引量:17
1
作者 Narendra Battula Parthi Srinivasan +4 位作者 mansoor madanur Srinivas Prabhu Chava Oliver Priest Mohamed Rela Nigel Heaton 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2007年第1期49-51,共3页
BACKGROUND: Transcatheter arterial chemoembolization (TACE) is a recommended first line therapy for unresectable hepatocellular carcinoma (HCC). Serious complications such as neutropenic sepsis and hepatic decompensat... BACKGROUND: Transcatheter arterial chemoembolization (TACE) is a recommended first line therapy for unresectable hepatocellular carcinoma (HCC). Serious complications such as neutropenic sepsis and hepatic decompensation are well known, but rupture of HCC following TACE is a rare and potentially fatal complication. The aim of this study was to identify the incidence of ruptured HCC following TACE and the associated risk factors. METHODS: A retrospective analysis was performed using our liver database with 'chemoembolization', 'ruptured HCC' covering the patients who received chemoembolization from January 1995 to December 2005. There were no exclusions. RESULTS: A total of 294 patients received chemoemboliza- tion in 530 sessions during the 10-year period. Of these, 2 ruptured following treatment (incidence 0.68%). The mean age was 65 years and the interval between the treatment and rupture was 2 and 24 days. The common factors were male sex, large tumor size (range 11-13 cm), and exophytic tumor growth. One patient died 2 days after rupture with hepatic decompensation while the second is alive after a 6-month follow up without tumor recurrence. CONCLUSIONS: Ruptured HCC following TACE is a rare but serious complication. Large tumor size, male sex, and exophytic growth of tumor may be predisposing factors for rupture. 展开更多
关键词 life-threatening complications CHEMOEMBOLIZATION RUPTURE carcinoma hepatocellular ruptured hepatocellular tumor
下载PDF
Non-functioning well-differentiated neuroendocrine tumor of the extrahepatic bile duct:an unusual suspect?
2
作者 Harsheet Sethi mansoor madanur +3 位作者 Parthi Srinivasan Bernard Portmann Nigel Heaton Mohamed Rela 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2007年第5期549-552,共4页
BACKGROUND:Neuroendocrine tumors(NETs)arising in the biliary tree are extremely rare,and 37 cases were identified in the English literature. METHODS:A well-differentiated NET was found arising from the junction of the... BACKGROUND:Neuroendocrine tumors(NETs)arising in the biliary tree are extremely rare,and 37 cases were identified in the English literature. METHODS:A well-differentiated NET was found arising from the junction of the cystic and common hepatic ducts, in a 51-year-old male presenting with pedal edema and weight loss with abnormal liver enzymes and a normal serum bilirubin level.No mass was seen on radiological imaging and biopsy of the liver was suggestive of an early cholangiopathy.A bile leak complicating the liver biopsy led to an ERCP that demonstrated a filling defect suggestive of a mass in the common bile duct(CBD). RESULTS:He underwent a successful excision of the tumor with a Roux-en-Y hepaticojejunostomy.The diagnosis of NET was made on histological and immunohistochemical analysis of the resected specimen.He remains well and disease free 22 months after surgery. CONCLUSIONS:Recognition of biliary NET continues to be a challenge and an increased awareness of these tumors in rare sites will result in optimal management of these tumors. 展开更多
关键词 CARCINOID neuroendocrine tumor BILIARY common bile duct
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部